NIH-funded research R21 grant

How age affects skin healing and the role of a specific protein

Official title: Roles of epidermal integrin α3β1 in age-dependent changes during cutaneous wound healing

Funded at Albany Medical College · NIH-11163509 · Data updated 2026-11-12

This study is looking at how getting older affects how our skin heals from wounds, especially focusing on a protein that helps with healing, to find ways to make it easier for older adults to recover from injuries.

More Wound research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionAlbany Medical College
NIH-funded
Lab location1 site (Albany, United States)
Project startAugust 15, 2024
Project endMay 31, 2026
Funding year2025
Award (this year)$174,988
NIH project number5R21AR083049-02
Project IDNIH-11163509 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals aged 65 and older who experience delayed wound healing.

Less likely to help

Patients under the age of 65 or those with specific comorbidities affecting wound healing may not benefit from this research.

What this research studies

This research investigates how aging impacts the healing of skin wounds, particularly focusing on a protein called integrin α3β1 that plays a crucial role in the healing process. The study aims to understand the changes in this protein as people age and how these changes may lead to slower healing and increased risk of infection in older adults. By using a specialized genetic model, researchers will explore the effects of reduced integrin α3β1 on skin healing in mice, which may provide insights applicable to human skin. The ultimate goal is to identify potential therapeutic targets to improve wound healing in the elderly.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance wound healing in older adults, reducing their risk of complications.

How similar studies have gone: Previous research has shown that targeting integrin proteins can improve healing processes, suggesting that this approach may yield beneficial results.

Where this research is happening

  • Albany Medical College
    Albany, United States
    Active

Researchers

  • Principal investigator: Longmate, Whitney Morgan — Albany Medical College
  • Study coordinator: Longmate, Whitney Morgan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.